Inno-6050 Site 21 — Miami Lakes, Florida

Inno-6050 Site 21 is a clinical research site located in Miami Lakes, Florida, United States 33014.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Inno-6050 Site 21 has participated in 1 clinical trials.

Therapeutic areas: Atopic Dermatitis.

Sponsors: Innovaderm Research Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Miami Lakes

Browse all research sites in Florida · View every site in Miami Lakes

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Inno-6050 Site 21?

Inno-6050 Site 21 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Inno-6050 Site 21 conducted?

Inno-6050 Site 21 has 1 clinical trials on record. Their work covers Atopic Dermatitis.

Is Inno-6050 Site 21 accredited by Crixeo Clinical Trials?

Inno-6050 Site 21 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Inno-6050 Site 21?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.